Search

Drugs Sector

Drugs Upgrades

Date
Ticker
Analyst
Old Rating
New Rating
01/25/2011
NVO
Goldman Sachs
Neutral
Buy
01/21/2011
WAG
Suntrust Robinson Humphrey
Neutral
Buy
01/19/2011
FRX
JPMorgan
Underweight
Neutral
01/18/2011
Gleacher & Co.
Neutral
Buy

Drugs Downgrades

Date
Ticker
Analyst
Old Rating
New Rating
01/26/2011
JNJ
Noble Financial
Buy
Hold
01/24/2011
An analyst at BofA/Merrill Lynch
Outperform
Neutral earlier
01/21/2011
BofA/Merrill Lynch
Neutral
Underperform
01/13/2011
ELN
UBS
Buy
Neutral

Drugs New Coverages

Date
Ticker
Analyst
Rating
11/09/2012
Mizuho Securities
Neutral
11/09/2012
Guggenheim
Buy
11/09/2012
LCI
Canaccord Genuity
Buy
11/09/2012
FRX
Mizuho Securities
Buy

Drugs Earnings

Date
Company
Actual
Expected
02/07/2013
0.21
0.41
02/01/2013
1.36
1.31
02/01/2013
0.83
0.81
01/15/2013
-0.58
-0.14

On This Date

February 8, 2000:
Pfizer confirms it will pay $93.4 billion to buy Warner-Lambert, thereby creating the world's No. 2 drug firm with $28 billion in revenue and $4.7 billion in annual R&D spending.